Translation and Validation of the French Version of the Sleep Regularity Questionnaire: a New Tool to Address the the Challenge of Sleep Health
NCT ID: NCT06727448
Last Updated: 2025-12-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2024-12-23
2026-06-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aging, Sleep, Cognitive Process
NCT00804804
Evaluation of Sleep Pattern and Mood Profile in Hypertensive Patients
NCT03163498
Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities
NCT06989619
Evaluation of e New Sleep Detection Device "Easy Sleep Monitoring"
NCT05696496
Disruption of Circadian Rhythm and Healthcare-related Infection in Patients With Severe Trauma
NCT02307747
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators make the following assumptions:
* Cronbach's alpha = 0.87 as in the English version.
* a two-dimensional structure with a circadian regularity factor and a sleep continuity regularity factor will be confirmed by confirmatory factor analyses.
* Convergent validity between SRQ results and actimetric measures of sleep regularity (Sleep Regularity Index, intra-individual variability).
The main objective of this study was to translate and validate the French version of the Sleep Regularity Questionnaire (SRQ).
The secondary objectives are to analyze the external validity (convergent and divergent) of the SRQ by calculating :
* associations with sleep complaints (insomnia, somnolence),
* mental health complaints (depression, anxiety),
* sleep behaviors and electroencephalographic parameters (sleep architecture, fragmentation).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
French patients indicated for 14-day actimetry for chronic insomnia or circadian rhythm disorders
SRQ questionnaire
SRQ questionnaire administered at inclusion visit and 14 days after inclusion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SRQ questionnaire
SRQ questionnaire administered at inclusion visit and 14 days after inclusion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with indication for 14-day actimetry for chronic insomnia or circadian rhythm disorder
* Patients with an indication for 14-day actimetry to assess sleep-wake rhythms, for example prior to a 36-hour polysomnographic recording to diagnose central hypersomnia (narcolepsy or idiopathic hypersomnia).
* Patient affiliated to or benefiting from a social security scheme
* Patient with French as mother tongue, able to read and write French.
* Patient able to understand and complete questionnaires independently
* Patient informed and not opposed to participating in the study
Exclusion Criteria
* Current neurological disorder affecting sleep (neurodegenerative disease, stroke, epilepsy) assessed during interview with investigator
* Unstable cardiovascular or respiratory diseases
* Pregnant or breast-feeding women
* Adults under guardianship or curatorship
* Opposition to participation expressed by healthy patient/volunteer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2024/13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.